Laporan Laba Rugi (TTM)
Laporan Laba Rugi Actinogen Medical Limited - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 7 | 10 | 9 | 9 | 7 | 5 |
| Change (%) | -10.86 | -14.91 | -17.53 | -1.26 | -1.28 | 44.10 | 30.61 | 13.79 | 12.12 | 2.62 | 2.56 | -0.97 | -0.98 | 53.61 | 34.90 | -4.58 | -4.80 | -19.58 | -24.34 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| Gross Operating Profit | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 7 | 10 | 9 | 9 | 7 | 5 |
| Change (%) | -10.86 | -14.91 | -17.53 | -1.26 | -1.28 | 44.10 | 30.61 | 13.79 | 12.12 | 2.62 | 2.56 | -0.97 | -0.98 | 53.61 | 34.90 | -4.58 | -4.80 | -19.58 | -24.34 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| SG&A | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 5 | 5 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 8 |
| Change (%) | -2.68 | 5.41 | 5.13 | 7.39 | 6.88 | 13.82 | 12.14 | 11.47 | 10.29 | 8.60 | 7.92 | 3.79 | 3.65 | 1.20 | 1.19 | 1.23 | 1.22 | 4.80 | 4.58 | |
| % of Revenue | 90.95 | 99.29 | 123.01 | 156.80 | 170.53 | 184.63 | 145.83 | 125.21 | 122.66 | 120.65 | 127.68 | 134.36 | 140.83 | 147.42 | 97.12 | 72.85 | 77.28 | 82.17 | 107.07 | 148.01 |
| R&D | 4 | 3 | 3 | 2 | 4 | 5 | 7 | 8 | 9 | 10 | 9 | 9 | 11 | 12 | 14 | 16 | 13 | 11 | 12 | 12 |
| Change (%) | -25.07 | -13.73 | -15.92 | 61.45 | 38.06 | 26.58 | 21.00 | 9.97 | 9.06 | -4.83 | -5.08 | 20.05 | 16.70 | 12.30 | 10.95 | -14.06 | -16.37 | 5.06 | 4.82 | |
| % of Revenue | 139.58 | 117.33 | 118.96 | 121.28 | 198.30 | 277.31 | 243.59 | 225.68 | 218.09 | 212.14 | 196.73 | 182.08 | 220.73 | 260.14 | 190.19 | 156.43 | 140.87 | 123.75 | 161.67 | 224.00 |
| OpEx | 8 | 7 | 6 | 6 | 8 | 9 | 11 | 13 | 15 | 16 | 16 | 16 | 18 | 20 | 22 | 23 | 21 | 19 | 20 | 21 |
| Change (%) | -15.21 | -5.00 | -5.26 | 28.70 | 22.30 | 20.88 | 17.27 | 10.19 | 9.24 | 0.05 | 0.05 | 12.84 | 11.38 | 8.11 | 7.50 | -9.06 | -9.96 | 4.89 | 4.66 | |
| % of Revenue | 243.89 | 232.00 | 259.04 | 297.57 | 387.86 | 480.50 | 403.05 | 361.90 | 350.43 | 341.44 | 332.88 | 324.74 | 370.05 | 416.25 | 292.97 | 233.47 | 222.51 | 210.44 | 274.46 | 379.70 |
| Operating Income | -5 | -4 | -4 | -4 | -6 | -7 | -8 | -10 | -10 | -11 | -11 | -11 | -13 | -15 | -14 | -13 | -12 | -10 | -13 | -15 |
| Change (%) | -18.23 | 2.51 | 2.45 | 43.87 | 30.49 | 14.77 | 12.87 | 8.81 | 8.10 | -1.02 | -1.03 | 18.99 | 15.96 | -6.27 | -6.69 | -12.42 | -14.18 | 27.05 | 21.29 | |
| % of Revenue | -143.89 | -132.00 | -159.04 | -197.57 | -287.86 | -380.50 | -303.05 | -261.90 | -250.43 | -241.44 | -232.88 | -224.74 | -270.05 | -316.25 | -192.97 | -133.47 | -122.51 | -110.44 | -174.46 | -279.70 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | -5.51 | -6.86 | -7.36 | -7.62 | -8.25 | -1.16 | -1.18 | 4.38 | 4.19 | -8.70 | -9.53 | 3.17 | 3.08 | 18.80 | 15.83 | 19.12 | 16.05 | 22.79 | 18.56 | |
| % of Revenue | -0.86 | -0.91 | -1.00 | -1.12 | -1.05 | -0.98 | -0.67 | -0.51 | -0.47 | -0.43 | -0.38 | -0.34 | -0.35 | -0.37 | -0.28 | -0.24 | -0.31 | -0.37 | -0.57 | -0.89 |
| Net Income | -4 | -4 | -4 | -4 | -6 | -7 | -8 | -9 | -10 | -11 | -11 | -11 | -13 | -15 | -14 | -13 | -11 | -10 | -12 | -15 |
| Change (%) | -18.74 | 3.67 | 3.54 | 43.90 | 30.51 | 14.59 | 12.73 | 8.65 | 7.96 | -1.75 | -1.78 | 19.15 | 16.07 | -6.14 | -6.54 | -12.99 | -14.92 | 26.28 | 20.81 | |
| % of Revenue | -141.53 | -129.01 | -157.18 | -197.32 | -287.57 | -380.15 | -302.28 | -260.91 | -249.13 | -239.89 | -229.68 | -219.98 | -264.67 | -310.26 | -189.58 | -131.34 | -119.77 | -107.03 | -168.06 | -268.37 |
Source: Capital IQ
